Relenza (zanamivir for inhalation)

Manufacturer: SmithKlineGlaxo 

Indication(s):  Treatment of uncomplicated acute illness due to influenza virus in adults and adolescents age 12 years and older who have been symptomatic for no more than two days.

Administration:  Inhaled orally using a hand-held, breath-activated device called a Diskhaler.

Pharmacology:  New class of drugs known as a neuraminidase inhibitor

WebRx Editorial Notes:  Best results obtained when used early on.  Shortens the typical course of the flu by about 1 day.  While one day doesn't seem like much at first it could mean the difference of a full day's work or lost productivity for many people.

1999, 2000, 2001, 2002 WebRx Pharmacy Palace